Buy Supernus Pharmaceuticals Stock | SUPN Stock Price & Latest News | Public.com
SUPN

Supernus Pharmaceuticals

$0.00 (0.00%)Today
    View Supernus Pharmaceuticals (SUPN) stock trends here

    About SUPN

    Supernus Pharmaceuticals, Inc. engages in the development and commercialization of products for the treatment of central nervous system diseases. Its neurology portfolio consists of Oxtellar XR and Trokendi XR, which treats patients with epilepsy. The firm also develops...Read more

    Buy any stock with any amount of money.

    Download the App
    Download the app

    What Wall Street Thinks

    Events

    List of events that could affect this stock.

    Earnings

    The value each share was expected to gain vs. the value that each share actually gained

    0.74
    0.5
    0.25
    0
    Q2 2020
    Q3 2020
    Q4 2020
    Q1 2021

    Expected EPS
    Q1 2021

    $0.29

    Actual EPS
    Q1 2021

    Stats

    Market Cap$1,32B
    Volume47
    Price-to-Earnings Ratio10.65
    Dividend Rate
    Dividend Yield
    1 Year High$31.99
    1 Year Low$13.12
    Open$24.15
    High$25.37
    Low$23.20

    Buy any stock with any amount of money.

    Download the App
    Download the app